Paul, M.S., Duncan, A.R., Genetti, C.A., Pan, H., Jackson, A., Grant, P.E., Shi, J., Pinelli, M., Brunetti-Pierri, N., Garza-Flores, A., Shahani, D., Saneto, R.P., Zampino, G., Leoni, C., Agolini, E., Novelli, A., Blümlein, U., Haack, T.B., Heinritz, W., Matzker, E., Alhaddad, B., Abou Jamra, R., Bartolomaeus, T., AlHamdan, S., Carapito, R., Isidor, B., Bahram, S., Ritter, A., Izumi, K., Shakked, B.P., Barel, O., Ben Zeev, B., Begtrup, A., Carere, D.A., Mullegama, S.V., Palculict, T.B., Calame, D.G., Schwan, K., Aycinena, A.R.P., Traberg, R., Genomics England Research Consortium, , Douzgou, S., Pirt, H., Ismayilova, N., Banka, S., Chao, H.T., Agrawal, P.B. (2023). Rare EIF4A2 variants are associated with a neurodevelopmental disorder characterized by intellectual disability, hypotonia, and epilepsy.  Am. J. Hum. Genet. 110(1): 120--145.

FBrf0255452

Research paper

Eukaryotic initiation factor-4A2 (EIF4A2) is an ATP-dependent RNA helicase and a member of the DEAD-box protein family that recognizes the 5' cap structure of mRNAs, allows mRNA to bind to the ribosome, and plays an important role in microRNA-regulated gene repression. Here, we report on 15 individuals from 14 families presenting with global developmental delay, intellectual disability, hypotonia, epilepsy, and structural brain anomalies, all of whom have extremely rare de novo mono-allelic or inherited bi-allelic variants in EIF4A2. Neurodegeneration was predominantly reported in individuals with bi-allelic variants. Molecular modeling predicts these variants would perturb structural interactions in key protein domains. To determine the pathogenicity of the EIF4A2 variants in vivo, we examined the mono-allelic variants in Drosophila melanogaster (fruit fly) and identified variant-specific behavioral and developmental defects. The fruit fly homolog of EIF4A2 is eIF4A, a negative regulator of decapentaplegic (dpp) signaling that regulates embryo patterning, eye and wing morphogenesis, and stem cell identity determination. Our loss-of-function (LOF) rescue assay demonstrated a pupal lethality phenotype induced by loss of eIF4A, which was fully rescued with human EIF4A2 wild-type (WT) cDNA expression. In comparison, the EIF4A2 variant cDNAs failed or incompletely rescued the lethality. Overall, our findings reveal that EIF4A2 variants cause a genetic neurodevelopmental syndrome with both LOF and gain of function as underlying mechanisms.

PMC9892767 (PMC) (EuropePMC)